Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

about

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

Item

http://www.wikidata.org/entity/Q45916506

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Scientific Summary from the Mo ...... m 10th Anniversary Conference.

@en

Scientific Summary from the Mo ...... ter Inflammatory Breast Cancer

@nl

type

Item

label

Scientific Summary from the Mo ...... m 10th Anniversary Conference.

@en

Scientific Summary from the Mo ...... ter Inflammatory Breast Cancer

@nl

prefLabel

Scientific Summary from the Mo ...... m 10th Anniversary Conference.

@en

Scientific Summary from the Mo ...... ter Inflammatory Breast Cancer

@nl

P1476

Scientific Summary from the Mo ...... m 10th Anniversary Conference.

@en

P2093

Angela Alexander

http://www.w3.org/2001/XMLSchema#string

Anthony Lucci

http://www.w3.org/2001/XMLSchema#string

Beth Overmoyer

http://www.w3.org/2001/XMLSchema#string

Bisrat G Debeb

http://www.w3.org/2001/XMLSchema#string

Esta Sterneck

http://www.w3.org/2001/XMLSchema#string

Fedor Berditchevski

http://www.w3.org/2001/XMLSchema#string

Francois Bertucci

http://www.w3.org/2001/XMLSchema#string

Gayathri R Devi

http://www.w3.org/2001/XMLSchema#string

James M Reuben

http://www.w3.org/2001/XMLSchema#string

Kenneth L van Golen

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory breast cancer clusters: A hypothesis

Inflammatory breast cancer: what we know and what we need to learn

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Inflammatory breast cancer: a model for investigating cluster-based dissemination.

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.

In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.

Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.

Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer.

P304

3607-3614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.21200

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Schneider

Wendy A Woodward

P577

2017-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29667990

http://www.w3.org/2001/XMLSchema#string

P932

5687177

http://www.w3.org/2001/XMLSchema#string